23:54 , Aug 7, 2017 |  BC Extra  |  Company News

Management tracks: Pfenex, Alvotech, uniQure

Biosimilars company Pfenex Inc. (NYSE-M:PFNX) named Evert Schimmelpennink CEO, president and secretary. He succeeds interim CEO Patrick Lucy, who will continue as CBO. Rasmus Rojkjaer was named CEO at biosimilar company Alvotech ehf (Reykjavik, Iceland),...
01:25 , May 10, 2016 |  BC Extra  |  Company News

Management tracks

Metabolic company Arena Pharmaceuticals Inc. (NASDQ:ARNA) named Amit Munshi CEO and interim principal financial officer. He was president and CEO at Epirus Biopharmaceuticals Inc. (NASDAQ:EPRS). Epirus named Scott Rocklage, a director, CEO and promoted Chief...
01:17 , Apr 21, 2016 |  BC Extra  |  Company News

Management tracks

Oncology play Checkmate Pharmaceuticals Inc. (Cambridge, Mass.) hired David Mauro as CMO. He was EVP and CMO at Advaxis Inc. (NASDAQ:ADXS). Rare disease company Lumos Pharma Inc. (Austin, Texas) hired John McKew as CSO. He...
07:00 , Aug 3, 2015 |  BC Week In Review  |  Company News

Danaher, Hologic sales and marketing update

The U.K.’s NICE issued final guidance recommending against the Prostate Health Index (PHI) from Danaher’s Beckman Coulter Inc. subsidiary and Progensa PCA3 assay from Hologic to diagnose prostate cancer in patients who have had a...
07:00 , May 26, 2014 |  BC Week In Review  |  Clinical News

Access AccuTnl+3 troponin I assay regulatory update

The U.K.'s NICE issued draft guidance recommending the Elecsys Troponin T high-sensitive assay from Roche (SIX:ROG; OTCQX:RHHBY, Basel, Switzerland) and the Architect Stat High Sensitive Troponin-I assay from Abbott Laboratories (NYSE:ABT, Abbott Park, Ill.) for...
07:00 , May 26, 2014 |  BC Week In Review  |  Clinical News

Elecsys Troponin T high-sensitive assay regulatory update

The U.K.'s NICE issued draft guidance recommending the Elecsys Troponin T high-sensitive assay from Roche and the Architect Stat High Sensitive Troponin-I assay from Abbott Laboratories (NYSE:ABT, Abbott Park, Ill.) for the early rule out...
07:00 , May 26, 2014 |  BC Week In Review  |  Clinical News

Architect Stat High Sensitive Troponin-I Assay regulatory update

The U.K.'s NICE issued draft guidance recommending the Elecsys Troponin T high-sensitive assay from Roche (SIX:ROG; OTCQX:RHHBY, Basel, Switzerland) and the Architect Stat High Sensitive Troponin-I assay from Abbott for the early rule out of...
07:00 , May 5, 2014 |  BC Week In Review  |  Company News

Danaher, Innovative Diagnostic Laboratory LLP sales and marketing update

Innovative Diagnostic launched the multivariate Prostate Health Index (phi) in the U.S. Innovative Diagnostic is a JV between GeneNews Ltd. (TSX:GEN, Richmond Hill, Ontario), Health Diagnostic Laboratory Inc. (Richmond, Va.) and an undisclosed sales company....
07:00 , Oct 7, 2013 |  BC Week In Review  |  Clinical News

Access AccuTnl+3 troponin I assay regulatory update

Danaher's Beckman Coulter Inc. subsidiary said FDA granted 510(k) clearance for its Access AccuTnl+3 troponin I assay for use on its UniCel DxI series of immunoassay systems to determine levels of cardiac troponin I in...
07:00 , Aug 19, 2013 |  BC Week In Review  |  Clinical News

Argos, Danaher preclinical data

In a mouse model of high-risk cornea transplant, topical administration of sCD83 via eye drops prolonged graft survival. Data were published in the Journal of Immunology. Argos has exclusive rights from Beckman Coulter Inc. to...